Quantcast

Marrone Bio Innovations to Attend Upcoming Investor Conferences in May

By GlobeNewswire,  May 01, 2019, 08:31:00 AM EDT


DAVIS, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced that management will attend the B. Riley FBR 20th Annual Investor Conference in Beverly Hills, California and the BMO Capital Markets 14th Annual Farm to Market Conference in New York City.

Pam Marrone, CEO and Founder of Marrone Bio Innovations, will host one-on-one meetings throughout the day for each event and is scheduled to present as follows:

BMO Capital Markets 14th Annual Farm to Market Conference

Date:Wednesday, May 15 - Thursday, May 16, 2019

Panel Presentation Time: 3:30pm - 4:00pm ET in Ballroom V

Location: Grand Hyatt New York - 109 E 42nd St, New York, NY 10017

B. Riley FBR 20th Annual Investor Conference

Date:  Wednesday, May 22 - Thursday, May 23, 2019

Presentation Time: Thursday, May 23, 2019 at 11:30 a.m. Pacific time in Room 2

Location: Beverly Hilton - 9876 Wilshire Blvd, Beverly Hills, CA 90210

Webcast: http://www.wsw.com/webcast/brileyfbr3/mbii

Conference participation is by invitation only and registration is mandatory. For more information or to schedule a one-on-one meeting at either conference, please contact your BMO Capital Markets or B. Riley FBR representative.

About Marrone Bio Innovations

Marrone Bio Innovations Inc. (NASDAQ:MBII) strives to lead the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that support a better tomorrow for farmers, turf managers and consumers around the globe. MBI has screened more than 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes, enhanced by advanced molecular technologies, to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of more than 400 issued and pending patents around its superior natural product chemistry, MBI's currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus®, Amplitude™, Zelto® and Zequanox®. TerraConnect™ is MBI's new seed treatment and soil-applied platform.

Learn more about Marrone Bio Innovations at www.marronebio.com. Follow us on social media: TwitterLinkedIn and Instagram.

Marrone Bio Innovations Contacts:

Pam Marrone, CEO and Founder

Telephone: +1 (530) 750-2800

Email: Info@marronebio.com

Investor Relations:

Greg Falesnik

Managing Director

MZ Group - MZ North America

Main: 949-385-6449

MBII@mzgroup.us

www.mzgroup.us

Source: Marrone Bio Innovations

This article appears in: News Headlines

Referenced Stocks: MBII










Today's Market Activity

NASDAQ 7845.02
48.36  ▲  0.62%
DJIA 26112.53
22.92  ▲  0.09%
S&P 500 2889.67
2.69  ▲  0.09%
Data as of Jun 17, 2019